This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Marie-Eve Beaulieu
CSO at PEPTOMYC
Speaker

Profile

Dr. Beaulieu is the co-founder and Chief Scientific Officer at Peptomyc, a biotech company developing mini-protein therapeutics for cancer treatment. PhD in Pharmacology with a strong focus on structural biology of proteins, Marie-Eve has lead the preclinical pharmaceutical development of OMO-103, the first direct MYC inhibitor to successfully complete a clinical trial showing safety and clinical activity in human patients in 2022. Marie-Eve also contributed to design the company strategy, build the team and fundraised public >11MEur and private ~30MEur capital. She currently leads Peptomyc’s pipeline expansion activities and the chemistry, manufacturing and controls activities related to OMO-103. Marie-Eve has co-authored 8 patent applications, 31 peer-reviewed publications and 4 book chapters (ORCID 0000-0001-5224-8436). She was awarded several competitive fellowships (eg. MITACS, FRSQ postdoctoral awards, Worldwide Cancer Research grant) and contributed to the company’s scientific and business excellence as testified by several local and international awards (eg BioFit, Best company initiative at AJIEC, EIT Health Headstart, J&J StartUpSlam at BioEurope, and the highly competitive H2020 SME Instrument and EIC Accelerator awards).

Agenda Sessions

  • Startup stories: how it started, how it’s going

    14:00